Awards & Recognition - VIVOS INC. (formerly AMIC) has been recognized as a leader by local, state and federal agencies.
• $1.3 million U.S. Federal grant for brachytherapy
• Leaders in Healthcare Award, Seattle Business Magazine
• Federal Laboratory Consortium Award for Excellence in Technology Transfer,
a prestigious honor recognized by the US Secretary of Energy and US Senator Murray
2015 - AMIC awarded $250,000 Life Sciences Discovery Fund Grant as Commercialization Partner
Focus: To test a novel technology for delivering high-dose radiation to solid cancers that cannot be removed surgically
Anticipated Impact: Safer, more effective treatment of radiation-resistant solid cancers
August 3, 2013 - The Secretary of Energy, Washington, D.C.
CURRENT RELEASE
Vivos Inc. Provides 2019 Recap and Outlines 2020 Objectives
Richland WA, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), provides 2019 recap and outlines future objectives. Vivos’ CEO, Dr. Mike Korenko stated, “as we begin 2020, I think it is important to review our progress during past year and to provide some insight on our goals and expectations for 2020 and beyond.”
2019 Key Highlight Include: >> Read Full Release
Stock Quote
Links
VIVOS Inc. (OTCQB: RDGL)
719 Jadwin Avenue. Richland, Washington 99352 US
T: 509.736.4000 E: mkorenko@radiogel.com